We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

3D-printed All-liquid "Lab-on-a-Chip" Could Transform Drug Candidate Screens

News   Apr 26, 2019 | Original story from DOE’s Lawrence Berkeley National Laboratory

 
3D-printed All-liquid "Lab-on-a-Chip" Could Transform Drug Candidate Screens

To make the 3D-printable fluidic device, Berkeley Lab researchers designed a specially patterned glass substrate. When two liquids - one containing nanoscale clay particles, another containing polymer particles - are printed onto the substrate, they come together at the interface of the two liquids and within milliseconds form a very thin channel or tube about 1 millimeter in diameter. Credit: Berkeley Lab

 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

Targeted Therapy Could Help Children With Deadly Nerve Cancer

News

Mount Sinai researchers have discovered a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE